SynAct Pharma CEO has Acquired Shares in the Company
LUND, SE / ACCESS Newswire / November 16, 2026 / SynAct Pharma AB (publ) ("SynAct") (Nasdaq Stockholm:SYNACT), a clinical-stage biotechnological company focused on treating inflammation through a novel therapeutic approach known as "pro-resolution", …
Weiterlesen »